Clinical Trial Update: Phase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial update for SY-3505 in ALK-positive advanced non-small cell lung cancer is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SY-3505

Snippet

Sponsor: Shouyao Holdings (Beijing) Co. LTD | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN